Repaglinide 0.5 mg Australia

Description

Introduction

Repaglinide 0.5 mg Australia is an oral tablet identified as containing 0.5 mg of the active ingredient repaglinide. Repaglinide is used to help manage blood glucose in type 2 diabetes. The exact inactive ingredients and full directions for a supplied pack should be checked with a pharmacist if needed.

What Is It?

Repaglinide belongs to a group of medicines called meglitinides. It is an oral glucose-lowering medicine, not insulin. It may form part of a type 2 diabetes care plan that also includes food choices, physical activity and blood glucose monitoring.

The stated strength is the amount of repaglinide in each tablet. It does not establish an appropriate dose or schedule for an individual. Treatment decisions depend on a clinician’s assessment of blood glucose results, other health conditions and other medicines.

How Does It Work?

Repaglinide stimulates the pancreas to release insulin. Insulin helps the body move glucose from the blood into its cells. Repaglinide’s effect is closely related to meals, so eating patterns are relevant to its use. Because it lowers blood glucose, it can cause hypoglycaemia, or blood glucose that falls too low.

The response to treatment can vary. Monitoring helps a healthcare professional assess whether a treatment plan is working and whether changes are needed.

Common Uses

Repaglinide is used to improve blood glucose control in type 2 diabetes. It may be considered within a broader management plan that includes diet and physical activity. Blood glucose readings and HbA1c results can help assess the response over time.

Repaglinide is not used to treat type 1 diabetes or diabetic ketoacidosis. Whether it should be used with another diabetes medicine requires individual clinical review.

Available Strengths

• Repaglinide 0.5 mg Australia
• Repaglinide 1 mg Australia
• Repaglinide 2 mg Australia

Key Features

• Active ingredient: repaglinide.
• Stated strength and form: 0.5 mg oral tablet.
• Stimulates insulin release from the pancreas to lower blood glucose.
• Has a meal-related effect, making eating patterns relevant to prescribed use.
• Requires awareness of low blood glucose and potential interactions with other medicines.

Benefits

• Can help lower elevated blood glucose in type 2 diabetes when used as prescribed.
• Provides an oral treatment option where a clinician determines repaglinide is appropriate.
• Its effect can be assessed with blood glucose readings and HbA1c measurements.

These characteristics do not guarantee a particular result. Diabetes management may also involve changes to food, activity and other aspects of care.

Possible Side Effects

• Hypoglycaemia is an important possible effect. Signs may include sweating, shakiness, hunger, headache, dizziness, weakness or irritability.
• Severe hypoglycaemia may cause confusion, seizures or loss of consciousness and requires urgent medical attention.
• Headache, constipation, diarrhoea, joint aches, back pain and nasal congestion have been reported with repaglinide.
• Blood glucose levels may change when meals, physical activity, illness or other medicines change.

Side effects vary between people. Seek medical advice for persistent or troublesome symptoms and urgent help for severe symptoms or a suspected serious reaction.

Precautions

• Tell a healthcare professional about any previous allergy to repaglinide or other medicines.
• Discuss liver or kidney disease before using repaglinide.
• Discuss pregnancy, plans for pregnancy or breastfeeding, as treatment may need review.
• Report episodes of low blood glucose, including episodes with few warning signs.
• Ask for guidance if meals are regularly missed or eating patterns change.

Additional Precautions

• Low blood glucose can impair concentration and reaction time, including while driving or operating machinery.
• Illness and changes in physical activity can affect blood glucose control.
• Alcohol can lower blood glucose. Discuss alcohol use with a healthcare professional.
• Tell treating clinicians and dentists about repaglinide before surgery or other procedures.
• Keep a current list of prescription medicines, non-prescription products and supplements for medication reviews.

Storage Instructions

• Keep tablets in their supplied packaging or container unless a pharmacist advises otherwise.
• Store at room temperature, away from excess heat and moisture. Follow any more specific directions on the supplied pack.
• Keep all medicines out of the sight and reach of children.
• Ask a pharmacist how to dispose of expired or unneeded tablets.

How to Take

• Use repaglinide as directed on the prescription and supplied medicine label.
• Repaglinide is used in relation to meals. Follow the instructions provided for the prescribed treatment plan.
• Ask a prescriber or pharmacist what to do if a meal is missed, a schedule changes or a dose is forgotten.
• Do not change the amount or frequency of treatment without professional advice.
• Follow the blood glucose monitoring plan agreed with the diabetes care team.

This description does not set an individual dose. A healthcare professional can explain the directions for the particular tablets supplied.

Drug Interactions

• Gemfibrozil can substantially increase exposure to repaglinide. This combination requires prescriber review and is generally avoided.
• Some antibiotics and antifungal medicines can alter repaglinide levels and its glucose-lowering effect.
• Rifampicin can change repaglinide levels or the response to treatment.
• Other glucose-lowering medicines may increase the risk of hypoglycaemia when used with repaglinide.
• Alcohol can affect blood glucose. Discuss alcohol use, medicines and supplements with a pharmacist or prescriber.

This is not a complete interaction list. The full combination of medicines should be checked before treatment changes.

Why Choose This Product?

• It is identified as a 0.5 mg oral tablet containing repaglinide for type 2 diabetes management.
• Repaglinide has an established glucose-lowering action through stimulation of insulin release.
• The tablet form offers an oral option when repaglinide is selected as part of an individual care plan.

Choice of medicine and strength should reflect a prescription and clinical review. Ask a pharmacist to confirm product-specific details, including inactive ingredients, for the pack supplied.

Frequently Asked Questions (FAQs)

What is the active ingredient?

The active ingredient identified for this product is repaglinide.

What strength is the tablet?

The stated strength is 0.5 mg of repaglinide per tablet.

What is repaglinide used for?

It is used to help manage blood glucose in type 2 diabetes.

Is repaglinide insulin?

No. It is an oral medicine that stimulates the pancreas to release insulin.

Can repaglinide cause low blood glucose?

Yes. Hypoglycaemia is an important possible effect. A healthcare professional can explain how to recognise and manage it.

Why do meals matter with repaglinide?

Its glucose-lowering effect is related to meals. Changes in eating patterns may affect blood glucose and the prescribed plan.

What if a meal is missed?

Follow the directions provided with the prescription or ask a pharmacist or prescriber for guidance.

Can it be used with other diabetes medicines?

Some combinations may be prescribed, but they require review because blood glucose can fall too low.

How should the tablets be stored?

Keep them away from excess heat and moisture, out of children’s reach, and follow the supplied pack’s directions.

Where can I check inactive ingredients?

A pharmacist can check the leaflet or packaging for the specific tablets supplied.